Partnering with us provides a number of strategic advantages:
At Colab Services, our strategic partners are never treated as just a demographic. True to our name, we work in a collaborative way — bringing companies and clinicians together to create meaningful partnerships that benefit all.
Led by clinicians ourselves, we understand the realities of practice and the importance of trust. That’s why we approach consultancy with the same care and respect we bring to clinical relationships. Our clinician partners are a professional cohort, not a sales target, and the services we help bring to market must add genuine value to their work.
This philosophy not only benefits practitioners, but also strengthens the companies we support. By ensuring alignment between healthcare providers and innovative solutions, we create sustainable partnerships that serve patients, clinicians, and businesses alike.
Case Study: Supporting PD Labs with growth in the UK Market
Background: With 25 years of proven excellence in the United States, PD Labs brings its precise, locally-crafted medications to the UK—Delivering consistent quality from their British laboratory, straight to your doorstep. For over 25 years, PD Labs has been committed to delivering personalised, high-quality compounded medications in the United States. They are proud to bring their innovative compounded medications to Britain, where they are expertly crafted in their state-of-the-art facility by skilled British chemists. Every medication is made locally, ensuring the highest standards of quality and care, and delivered directly to your doorstep for ultimate convenience. PD Labs’ UK chemists have completed extensive training in PD Labs’ proprietary techniques and share our unwavering commitment to precision and quality.
Challenge: The UK has a regulatory complexity, limited clinician networks, lack of brand awareness, so these are all challenges that PD Labs have had to navigate.Our Role: We have worked with PD Labs on market strategy relating to Conference event attendance and stand support, connected them directly with specific functional practitioners who require their service, delivered promotional and speaker opportunities, and shared operational advice, both pre-UK launch and since.
Results: Tangible outcomes include faster adoption by clinicians, expanded patient reach, improved product positioning and a key focus relating to prescribing for complex, chronic health conditions such as CIRS which is a very under-served market.
PD Labs offer
